Programme final Day 1, 24 November | Day 2, 25 November | Day 3, 26 November | Day 4, 27 November Time Day 1 (24 November) 9.30-9.45 Introduction to ESCAIDE 2020 09.45-11.00 Preparation Fireside panel 1a Abstract presentations viewing 11.00-11.40 Fireside Panel 1a (Live Q&A session) Moderated by: Ettore Severi Topic: Food and waterborne diseases outbreaks 1. Outbreak of Yersinia enterocolitica in Norway, 2020, Trude M Lyngstad 2. A Campylobacter jejuni outbreak linked to contaminated pasteurized milk in Denmark, 2020: a matched case-control study, Luís Alves de Sousa 3. Nuts about salmonella: consumption of brazil nuts and nut bars identified as risk factor for Salmonella Typhimurium t5.6145 in case-control study, United Kingdom, May - July 2020, Ranya Mulchandani 4. An outbreak of nalidixic acid and ciprofloxacin resistant Salmonella Enteritidis linked to eggs from Poland, Austria, 2019, Lukasz Henszel 5. Investigation of an outbreak of ESBL- producing Salmonella Kentucky in humans linked to poultry in Malta, 2013- 2020, Raquel Medialdea Carrera 11.40-12.00 Poster mingle 12.00-15.00 12.00-13.30 12.00-15.00 Side event: GOARN, 20 years Side event: Workshop epitweetr supporting international outbreak Limited places available. response 15.00-16.00 Preparation Fireside panel 1b Abstract presentations viewing 16.00-16.40 Fireside Panel 1b (Live Q&A session) Moderated by: Therese Westrell Topic: Food and waterborne diseases outbreaks (other) 6. Epidemiological investigation of eight cases of lethal encephalitis caused by newly detected zoonotic Borna disease virus 1 in Germany, 2019-2020, Kirsten Pörtner 7. Tracking the origin of Austrian human Brucellosis cases using whole genome sequencing, 2005-2019, Justine Schaeffer 8. Molecular typing as a tool to investigate the national increase of cryptosporidiosis cases in Sweden autumn/winter 2019, Jessica Beser 9. Risk assessment of foodborne Hepatitis E virus in Italy, Ornella Moro 10. A Campylobacter outbreak warning tool in Denmark: (less) time, (more) place and person, Guido Benedetti 16.40-17.00 Interactive break 17.00-18.00 Side event: Career Compass Limited places available PLENARY SESSIONS ABSTRACT-LED SESSIONS SIDE EVENTS INTERACTIVE MOMENTS 1 Day 1, 24 November | Day 2, 25 November | Day 3, 26 November | Day 4, 27 November Time Day 2 (25 November) 9.30-9.45 Introduction to ESCAIDE 2020 09.45-11.00 Preparation Fireside panel 2a Abstract presentations viewing 11.00-11.30 Fireside panel 2a (Live Q&A session) Moderated by: Erika Duffell Topic: HIV, sexually transmitted infections and blood infections 11. CD4/CD8-ratio trajectories in ClinSurv, a large multicentre HIV-cohort study from Germany 1999-2018, Kirsten Pörtner 12. Low vaccination coverage for Human papillomavirus disease among men who have sex with men in France, 2019, Giuseppina Ortu 13. An Evaluation of Gram-negative Bloodstream Infections Surveillance across Hospital Trusts in East of England, 2019, Nastassya Lakshmi Chandra 14. Evaluation of the National Surveillance System for Notifiable Sexually Transmitted Infections, Portugal, 2015-2018, Héloïse Lucaccioni 11.30-12.00 Poster mingle 12.00-14.00 Side event: MediPIET 14.00-15.00 Preparation Fireside panel 2b Abstract presentations viewing 15.00-15.30 Fireside panel 2b (Live Q&A session) Moderated by: Kari Johansen Topic: Vaccine-preventable diseases 15. Brand-specific influenza vaccine effectiveness against laboratory-confirmed influenza in Europe – results from the DRIVE network 2019/20, Anke Stuurman 16. Vaccine effectiveness against influenza A(H1N1)pdm09, A(H3N2) and B: Results from the 2019/20 European I- MOVE primary care multicentre study, Esther Kissling 17. Healthcare provider knowledge of and barriers to pneumococcal vaccination in at risk adults: survey results in Ireland 2020, Niamh Bambury 18. Universal infant vaccination against hepatitis B: is the end of risk-group HBV vaccination for MSM approaching?, Maria Xiridou 15.30-16.30 Preparation Fireside panel 2c Abstract presentations viewing 16.30-17.00 Fireside panel 2c (Live Q&A session) Moderated by: Angeliki Melidou Topic: Influenza and other respiratory viruses 19. Excess hospitalizations associated with RSV among children under 5 years old in France from 2010 to 2018, Demont Clarisse 20. Burden of hospitalization due to respiratory syncytial virus (RSV)-very severe associated lower respiratory tract infection (VS-ALRI) in the first year of life in a major urban city, Lyon, France, Jean-sebastien Casalegno 21. Novel methods in the surveillance of influenza-like illness (ILI): exploration of data from the symptom assessment app Ada, Caoimhe Cawley 22. Supervised learning of syndromes from emergency department data to improve syndromic surveillance of influenza-like illness in Germany, Birte Wagner 19.00-20.30 Side-event: EAN General Assembly Closed event PLENARY SESSIONS ABSTRACT-LED SESSIONS SIDE EVENTS INTERACTIVE MOMENTS 2 Day 1, 24 November | Day 2, 25 November | Day 3, 26 November | Day 4, 27 November Time Day 3 (26 November) 09.45-09.50 Introduction to ESCAIDE 2020 09.50-10.00 Message from ECDC Director, Andrea Ammon 10:00-10:10 Message from ESCAIDE Scientific Committee Chair, Mike Catchpole 10:15-11.45 Keynote session on COVID-19 Chaired by Mike Catchpole (ECDC) & Magdalena Rosińska (NIPH-NIH) Speaker A1: George Fu Gao, China CDC Speaker A2: Andrea Ammon, ECDC Speaker A3: Maria van Kerkhove, WHO 11.45-13.00 Preparation Fireside panel 3a Abstract presentations viewing 13.00-13.30 Fireside panel 3a (Live Q&A session) Moderated by: Eeva Broberg Topic: COVID-19 Serology and prevalence 23. The Study to Investigate COVID-19 Infection in People Living in Ireland (SCOPI): A national seroprevalence study, June-July 2020, Patricia Garvey 24. SARS-CoV-2 prevalence and seroprevalence among healthcare workers in Belgian hospitals: preliminary results of a prospective cohort study, Laure Mortgat 25. Seroepidemiologic study to detect antibody-mediated immunity against SARS-CoV-2 among residents and healthcare workers in the city of Plovdiv, Bulgaria, weeks 21-24, 2020, Savina Stoitsova 26. Seroprevalence for SARS-CoV-2 and associated factors in the Rinkeby-Kista district of Stockholm, Sweden, 22–24 June 2020, Jessica Beser 13.30-14.10 Preparation Fireside panel 3b Abstract presentations viewing 14.10-14.40 Fireside panel 3b (Live Q&A session) Moderated by: Tarik Derrough Topic: COVID-19 response 27. Changes in behaviour of the UK population due to COVID-19, March to June 2020, Sarah Foulkes 28. Community Engagement Interviews to Assess Feasibility of Shielding and Inform COVID-19 Response in IDP Camps in Nigeria, Emily Briskin 29. Establishing a COVID-19 Pandemic Severity Assessment surveillance system in Ireland - preliminary findings, Lisa Domegan 30. A traffic light model for infection prevention guidelines in Norwegian schools: experiences with adjusted levels of measures, COVID-19 pandemic, 2020, Tone Johansen 14.40-15.20 Preparation Fireside panel 3c Abstract presentations viewing 15.20-15.50 Fireside panel 3c (Live Q&A session) Moderated by: Cornelia Adlhoch Topic: COVID-19 Surveillance 31. Comparison of secondary attack rates resulting from asymptomatic, presymptomatic and symptomatic cases in a COVID-19 outbreak in Freising district, Germany, February-March 2020, Jennifer Bender 32. Role of returning travellers and control measures on the dynamics of COVID-19 in Bavaria, Stefanie Böhm 33. The COVID-19 epidemic in Spain: Characterisation of cases and risk factors for severe outcomes, Despina Pampaka 34. COVID-19: Determinants of Hospitalization, ICU admission and Death among 20,293 reported cases in Portugal, Vasco Ricoca Peixoto PLENARY SESSIONS ABSTRACT-LED SESSIONS SIDE EVENTS INTERACTIVE MOMENTS 3 Time Day 3 (26 November) 16.00-17.30 Plenary B: Pandemic preparedness in times of COVID-19: how have pandemic preparedness plans contributed to responding to this global public health threat? Chaired by Vicky Lefevre (ECDC) & Frode Forland (Norwegian Institute of Public Health) Speaker B1: Devi Sridhar (University of Edinburgh, United Kingdom) Speaker B2: Gabrielle Breugelmans (CEPI, Norway) Speaker B3: Anders Tegnell (Public Health Agency, Sweden) Speaker B4: Francesco Maraglino (Ministry of Health, Italy) 17.30-18.00 Poster mingle 18.00-18.30 Wrap-up session Day 1, 24 November | Day 2, 25 November | Day 3, 26 November | Day 4, 27 November Time Day 4 (27 November) 9.30-9.45 Introduction to ESCAIDE 2020 9.45-10.15 Interactive break 10:15-11.45 Plenary C: Magic bullet to control antimicrobial resistance (AMR): behaviour change or new technologies? Chaired by Bojana Beović (University of Ljubljana) & Bruno Coignard (Santé publique France) Speaker C1: Esmita Charani (Imperial College London) Speaker C2: A.W. (Alex) Friedrich (University of Groningen) Speaker C3: Stephan Harbarth (Hôpitaux Universitaires de Genève) 11.45-13.00 Preparation Fireside panel 4a Abstract presentations viewing 13.00-13.30 Fireside panel 4a (Live Q&A session) Moderated by: Pete Kinross Topic: Antimicrobial resistance 35. Comparison of phenotypic and genotypic antimicrobial susceptibility testing of VRE and ESBL isolates in Sweden, 2016-2018, Maximilian Riess 36. ESBL/pAmpC-producing Escherichia coli and Klebsiella pneumoniae carriage among veterinary healthcare workers in the Netherlands, Anouk Meijs 37. Estimating the impact of stewardship programmes on antibiotic consumption in EU. Evidence from the Eurobarometer for the years 2009-2018, Niccolò Stamboglis 38. CPE OXA-48 hospital ward outbreak in Ireland 2018-2019 - investigation of transmission patterns using social network analysis and genomics, Lisa Domegan and Carina Brehony 13.30-14.10 Preparation Fireside panel 4b Abstract presentations viewing 14.10-14.40 Fireside panel 4b (Live Q&A session) Moderated by: Anastasia Pharris Topic: COVID-19 Field epidemiology 39. Risk factors for outbreaks of COVID-19 in adult care facilities following hospital discharge: a national cohort analysis, James Adamson 40. Risk factors associated with an outbreak of COVID-19 in a meat-processing plant in Germany, April 2020, Iris Finci PLENARY SESSIONS ABSTRACT-LED SESSIONS SIDE EVENTS INTERACTIVE MOMENTS 4 Time Day 4 (27 November) 41.